Clinical Trial Update: Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial in cancer patients to evaluate elsiglutide for preventing chemotherapy-induced diarrhea; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• Elsiglutide (elsiglutide)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Diarrhea | Phase 2 | Status: COMPLETED